ASH 2018 | Key updates in therapies for acute leukemias from ASH 2018

Name: Key updates in therapies for acute leukemias from ASH 2018
Uploaded: 2018-12-06T13:03:55.000Z
Duration: 53 s
Description: Daniel DeAngelo, MD, PhD, of the Dana-Farber Cancer Institute, Boston, MA, gives his take on the highlights for acute leukemia from the American Society of Hematology (ASH) 2018 Annual Meeting and Exposition in San Diego, CA.

Daniel DeAngelo • 6 Dec 2018

ASH 2018

Acute Lymphoblastic Leukemia Acute Myeloid Leukemia Leukemia Venetoclax

Daniel DeAngelo, MD, PhD, of the Dana-Farber Cancer Institute, Boston, MA, gives his take on the highlights for acute leukemia from the American Society of Hematology (ASH) 2018 Annual Meeting and Exposition in San Diego, CA.